Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of … – Citizen Tribune,

The first volunteer receives Akston Bioscience’s COVID-19 vaccine candidate, AKS-452, as part of a Phase II clinical trial in India., The first volunteer receives Akston Bioscience’s COVID-19 vaccine candidate, AKS-452, as part of a Phase II clinical trial in India., Read More

Scroll to Top